Anna Leisvuori

Biodegradable Protections for Nucleoside 5′-Monophosphates: Comparative Study on the Removal of <i>O</i>-Acetyl and <i>O</i>-Acetyloxymethyl Protected 3-Hydroxy-2,2-bis(ethoxycarbonyl)propyl Groups

Mikko Ora, Sharmin Taherpour, Risto Linna et al. · The Journal of Organic Chemistry · 2009 · 16 citations

Synthesis of 3′,5′‐Cyclic Phosphate and Thiophosphate Esters of 2′‐<i>C</i>‐Methyl Ribonucleosides

Anna Leisvuori, Zafar Ahmed, Mikko Ora et al. · Helvetica Chimica Acta · 2012 · 14 citations

Inhibitory Activity, Biosynthesis, Engineering +15

[PP.02.17] SUCCESSFUL COMPLETION OF A PHASE I, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, SINGLE ASCENDING DOSE TRIAL FOR THE FIRST IN CLASS ANGIOTENSIN AT2-RECEPTOR AGONIST COMPOUND 21

U. Muscha Steckelings, L. Lindblad, Anna Leisvuori et al. · Journal of Hypertension · 2017 · 12 citations

Hypertension, Cardiovascular Pharmacology, Renal Inflammation +17

Chemical and enzymatic stability of amino acid derived phosphoramidates of antiviral nucleoside 5′-monophosphates bearing a biodegradable protecting group

Anna Leisvuori, Yuichiro Aiba, Tuomas Lönnberg et al. · Organic & Biomolecular Chemistry · 2010 · 10 citations